Component: (Network and Table) | |
---|---|
Network | 000140 - Statement - Consolidated Statements of Cash Flows (http://teletech.com/role/StatementConsolidatedStatementsOfCashFlows) |
Table | (Implied) |
Reporting Entity [Axis] | 0001013880 (http://www.sec.gov/CIK) |
Consolidated Statements of Cash Flows [Abstract] | Period [Axis] | ||
---|---|---|---|
2016-01-01 - 2016-12-31 | 2015-01-01 - 2015-12-31 | 2014-01-01 - 2014-12-31 | |
Consolidated Statements of Cash Flows [Abstract] | |||
Cash flows from operating activities | |||
Net income | 37,435,000 | 65,885,000 | 77,417,000 |
Adjustment to reconcile net income to net cash provided by operating activities: | |||
Depreciation and amortization | 68,675,000 | 63,808,000 | 56,538,000 |
Amortization of contract acquisition costs | |||
Amortization of debt issuance costs | |||
Imputed interest expense and fair value adjustments to contingent consideration | ( | ( | |
Provision for doubtful accounts | |||
Gain on disposal of assets | ( | ( | |
Impairment losses | 32,050,000 | 8,100,000 | 373,000 |
Loss on assets held-for-sale | 5,300,000 | 0 | 0 |
Deferred income taxes | ( | ||
Excess tax benefit from equity-based awards | ( | ( | ( |
Equity-based compensation expense | |||
(Gain) loss on foreign currency derivatives | ( | ( | |
Changes in assets and liabilities, net of acquisitions: | |||
Accounts receivable | ( | ( | ( |
Prepaids and other assets | ( | ( | ( |
Accounts payable and accrued expenses | ( | ( | |
Deferred revenue and other liabilities | ( | ( | |
Net cash provided by operating activities | |||
Cash flows from investing activities | |||
Proceeds from sale of long-live assets | |||
Purchases of property, plant and equipment | ( | ( | ( |
Investments in non-marketable equity investments | ( | ( | |
Acquisitions, net of cash acquired of zero and zero, respectively | ( | ( | ( |
Net cash used in investing activities | ( | ( | ( |
Cash flows from financing activities | |||
Proceeds from line of credit | |||
Payments on line of credit | ( | ( | ( |
Payments on other debt | ( | ( | ( |
Payments of contingent consideration and hold back payments to acquisitions | ( | ( | ( |
Dividends paid to shareholders | ( | ( | |
Payments to noncontrolling interest | ( | ( | ( |
Purchase of mandatorily redeemable noncontrolling interest | ( | ||
Proceeds from exercise of stock options | |||
Excess tax benefit from equity-based awards | |||
Payments of debt issuance costs | ( | ( | |
Purchase of treasury stock | ( | ( | ( |
Net cash used in financing activities | ( | ( | |
Effect of exchange rate changes on cash and cash equivalents | ( | ( | ( |
Increase (decrease) in cash and cash equivalents | ( | ( | ( |
Cash and cash equivalents, beginning of period | 60,304,000 | ||
Cash and cash equivalents, end of period | 55,264,000 | 60,304,000 | 77,316,000 |
Supplemental disclosures | |||
Cash paid for interest | |||
Cash paid for income taxes | |||
Non-cash investing and financing activities | |||
Acquisition of long lived assets through capital leases | |||
Acquisition of equipment through increase in accounts payable, net | ( | ( | |
Contract acquisition costs credited to accounts receivable |